A detailed history of Trustcore Financial Services, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Trustcore Financial Services, LLC holds 600 shares of HBIO stock, worth $1,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 600 -0.0%
Holding current value
$1,284
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

BUY
$5.16 - $7.14 $3,096 - $4,284
600 New
600 $4,000
Q4 2021

Feb 09, 2022

SELL
$6.37 - $8.18 $3,822 - $4,908
-600 Closed
0 $0
Q1 2019

May 07, 2019

BUY
$2.77 - $4.38 $1,662 - $2,628
600 New
600 $3,000
Q4 2018

Feb 05, 2019

SELL
$3.03 - $5.0 $1,817 - $3,000
-600 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$5.0 - $6.65 $3,000 - $3,990
600 New
600 $3,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.